Publications in collaboration with researchers from Hospital Universitari Sant Joan de Reus (10)

2026

  1. Brief report: Artificial intelligence meets small cell lung cancer—integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC

    Frontiers in Artificial Intelligence, Vol. 9

  2. Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1

    International Journal of Molecular Sciences, Vol. 27, Núm. 14

2025

  1. Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial

    Lung Cancer, Vol. 209

  2. Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial

    ESMO Open, Vol. 10, Núm. 10

  3. MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer

    Cell Reports Medicine, Vol. 6, Núm. 7

2024

  1. Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer

    Clinical Cancer Research, Vol. 30, Núm. 14, pp. 3036-3049

2022

  1. SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA

    Future Oncology, Vol. 18, Núm. 34, pp. 3791-3800

2003

  1. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

    Annals of Oncology, Vol. 14, Núm. 6, pp. 867-872

2002

  1. Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer

    British Journal of Cancer, Vol. 86, Núm. 3, pp. 326-330

2000

  1. Diagnóstico y manejo del carcinoma "in situ" testicular

    Archivos Espanoles de Urologia, Vol. 53, Núm. 6, pp. 443-446